Alexander Deneka
Temple University
H-index: 12
North America-United States
Top articles of Alexander Deneka
Loss of Pkd1 limits susceptibility to colitis and colorectal cancer
Oncogenesis
2023/8/5
MSI2 regulates DNA damage response signaling and tumor progression in murine NSCLC
Cancer Research
2023/4/4
Alexander Deneka
H-Index: 7
Christopher Lengner
H-Index: 38
Jyoti Patel
H-Index: 23
John Karanicolas
H-Index: 24
Yanis Boumber
H-Index: 20
Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6).
bioRxiv
2023
Musashi-2 (MSI2) regulation of DNA damage response in lung cancer
bioRxiv
2023
Alexander Deneka
H-Index: 7
Christopher Lengner
H-Index: 38
John Karanicolas
H-Index: 24
Yanis Boumber
H-Index: 20
MSI2 regulates VEGFR2 signaling and tumor progression in NSCLC
Cancer Research
2022/6/15
Loss of Pkd1 limits colorectal cancer by increasing colon barrier function
Cancer Research
2022/6/15
NEDD9 restrains dsDNA damage response during non-small cell lung cancer (NSCLC) progression
Cancers
2022/5/20
Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer
Clinical Cancer Research
2022/5/2
NEDD9 sustains hexokinase expression to promote glycolysis
Oncogenesis
2022/4/11
Evaluation of the small-molecule BRD4 degrader CFT-2718 in small-cell lung cancer and pancreatic cancer models
Molecular cancer therapeutics
2021/8/1
Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression
PloS one
2021/7/8
Nedd9 controls autophagy to limit non-small cell lung cancer (NSCLC) growth
Cancer Research
2021/7/1
Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer
Cancer research
2021/7/1
Targeting the epidermal growth factor receptor in EGFR-mutated lung cancer: current and emerging therapies
2021/6/24
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
Oncogenesis
2021/3/15
Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
Journal of Thoracic Disease
2021/3
Prognostic significance of Musashi 2 (MSI2) RNA-binding protein expression in precancerous polyps and during colorectal cancer (CRC) progression.
2020/5/20
Correlation of tumor mutational burden (TMB) with CDKN2A and TP53 mutation in HPV-negative head and neck squamous cell carcinoma (HNSCC).
2020/5/20
A comprehensive tyrosine phosphoproteomic analysis reveals novel components of the platelet CLEC-2 signaling cascade
Thrombosis and Haemostasis
2020/2
Synthetic lethal targeting of mitotic checkpoints in HPV-negative head and neck cancer
Cancers
2020/1/28
Co-Authors
